Using the medidux smartphone app to manage discharge from the Acute Admission Unit
Efficiency of the "Medidux" Smartphone App for Demission Management in Patients Medicated in Acute Admission Unit (AAU): a Randomized Controlled Trial.
We will test whether adults discharged from the Acute Admission Unit with cough, back pain, or abdominal discomfort who use the medidux app are less likely to return or need extra medical visits within 7 days.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 417 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mobile Health AG Industry-sponsored |
| Locations | 1 site (Horgen, Canton of Zurich) |
| Trial ID | NCT06655337 on ClinicalTrials.gov |
What this trial studies
This interventional trial compares the medidux smartphone app with standard post-discharge care for adults admitted to an Acute Admission Unit with non-urgent complaints such as cough, back pain, or abdominal discomfort. Eligible participants use the app to report symptoms and basic vital signs daily for seven days after discharge while a control group receives usual care. Investigators will compare rates of AAU readmission, emergency hospitalizations, and consultations with other medical providers within seven days. The trial is run at Notfallzentrum See-Spital Horgen and requires German-speaking participants who own a smartphone.
Who should consider this trial
Good fit: Adults aged 18 or older, triaged as ESI 4 or 5 at AAU presentation with a primary complaint of cough, back pain, or abdominal discomfort, who speak German and own an iOS or Android smartphone.
Not a fit: Patients with urgent or severe conditions, those without a compatible smartphone or sufficient smartphone skills, non-German speakers, or people already using a similar monitoring system are unlikely to benefit.
Why it matters
Potential benefit: If successful, the app could reduce short-term returns to the AAU and unplanned medical visits by improving symptom monitoring and early guidance after discharge.
How similar studies have performed: Previous digital symptom-monitoring and post-discharge apps have shown mixed but sometimes positive results in reducing readmissions in selected settings, though evidence is limited for non-urgent AAU discharges.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Signed Informed Consent Form (ICF) * Age ≥ 18 years * (Self-)admission to the involved Acute Admissions Unit (AAU) * "Lead symptom" identified as coughing, back pain or abdominal discomfort * Participant within ESI triage system group 4 (standard) and 5 (non-urgent) * German-speaking * Ownership of a smartphone or other mobile device with iOS or Android operating system Exclusion Criteria: * Age \< 18 years * Participant whose compliance to the study's protocol, e.g. due to mental health problems, physical problems, or the private life situation, can be justifiably doubted * Participant with insufficient knowledge about the use of a smartphone or other mobile device with iOS or Android operating system * Participant already using or planning to use another comparable electronic patient-reported symptom monitoring system (e.g. CANKADO) during this trial
Where this trial is running
Horgen, Canton of Zurich
- Notfallzentrum See-Spital Horgen — Horgen, Canton of Zurich, Switzerland (Recruiting)
Study contacts
- Study coordinator: Andreas Trojan, MD
- Email: andreas.trojan@mobilehealth.ch
- Phone: +41763430200
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.